John L. Lamattina, Director at LIGAND PHARMACEUTICALS INC (LGND), sold 6,670 shares at $254.96 ($1.7M) on 2018-09-04, disclosed to the SEC on 2018-09-05.
Open-market sale of $1.7M LGND by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $254.96 | 3,335 | $850K | 50.0% |
| 2 | $254.96 | 3,335 | $850K | 50.0% |
| Total | $254.96 avg | 6,670 | $1.7M | 100% |
| Filing → |
| LGND | SELL | 2025-11-12 | $1.7M | — | Filing → |
| LGND | SELL | 2024-12-02 | $595K | — | Filing → |
| LGND | SELL | 2021-11-17 | $1.6M | — | Filing → |